Valore202020212022202320242025TTMSpese di vendita, generali e amministrative226.13 M265.86 M252.41 M259.47 M263.93 M265.23 M265.23 MRicerca e sviluppo———————Reddito operativo297.4 M329.92 M-22.41 M342.43 M336.77 M309.41 M309.41 MProventi non operativi, Totale1.73 M-996 K-2.51 M604 K-5.11 M-9.71 M-9.71 MOneri finanziari, al netto degli interessi capitalizzati82.33 M64.29 M69.16 M5.2 M1.8 M1.38 M1.38 MProventi non operativi, esclusi gli oneri finanziari-81.96 M-64.23 M-69.33 M-5.35 M-1.96 M-1.52 M-1.52 MEntrate/uscite straordinarie1.37 M-1.05 M-2.34 M756 K-4.95 M-9.57 M-9.57 MUtile al lordo delle imposte204.11 M262.46 M-93.92 M276.02 M284.19 M257.5 M480.08 MQuota di utile———————Imposte39.43 M57.08 M-11.61 M66.69 M69.58 M67.19 M67.19 MInteressi di minoranza———————Altri proventi/oneri al netto delle imposte7.85 M9 000-447 K0-1.41 M0—Utile netto al lordo delle attività cessate164.68 M205.38 M-82.31 M209.34 M214.6 M190.3 M190.3 MAttività cessate———————Utile netto164.68 M205.38 M-82.31 M209.34 M214.6 M190.3 M190.3 MRegolazione della diluizione———————Dividendi privilegiati———————Utile netto diluito attribuibile agli azionisti ordinari164.68 M205.38 M-82.31 M209.34 M214.6 M190.3 M190.3 MUtile base per azione (EPS base)3.284.09-1.654.214.323.933.93Utile diluito per azione (EPS diluito)3.254.04-1.654.174.293.913.91Numero medio di azioni ordinarie in circolazione50.21 M50.26 M49.89 M49.76 M49.7 M48.46 M—Azioni diluite in circolazione50.6 M50.84 M49.89 M50.18 M50.08 M48.72 M—EBITDA327.57 M362.01 M10.21 M440.26 M414.58 M288.01 M298.34 MEBIT297.4 M329.92 M-22.41 M275.27 M289.14 M256.74 M267.07 MCosto del fatturato395.89 M466.17 M502.43 M500.91 M503.3 M493.13 M493.13 MAltri costi del venduto———————Ammortamento e svalutazione (liquidità)30.16 M32.09 M32.63 M30.68 M30.17 M31.27 M31.27 M
Prestige Consumer Healthcare Inc. Common Stock
Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.
Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano.
The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015.